These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12943736)

  • 1. Tissue glucocorticoid resistance/hypersensitivity syndromes.
    Kino T; De Martino MU; Charmandari E; Mirani M; Chrousos GP
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):457-67. PubMed ID: 12943736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes.
    Kino T; Chrousos GP
    J Endocrinol; 2001 Jun; 169(3):437-45. PubMed ID: 11375113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms.
    Charmandari E; Kino T; Chrousos GP
    Ann N Y Acad Sci; 2004 Jun; 1024():168-81. PubMed ID: 15265781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids.
    Kino T
    Horm Metab Res; 2007 Jun; 39(6):420-4. PubMed ID: 17578758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism.
    De Martino MU; Alesci S; Chrousos GP; Kino T
    Ann N Y Acad Sci; 2004 Jun; 1024():72-85. PubMed ID: 15265774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary generalized glucocorticoid resistance and hypersensitivity: the end-organ involvement in the stress response.
    Charmandari E
    Sci Signal; 2012 Oct; 5(244):pt5. PubMed ID: 23033539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity.
    Charmandari E; Kino T; Chrousos GP
    Endocr Dev; 2013; 24():67-85. PubMed ID: 23392096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial/sporadic glucocorticoid resistance syndrome and hypertension.
    Kino T; Vottero A; Charmandari E; Chrousos GP
    Ann N Y Acad Sci; 2002 Sep; 970():101-11. PubMed ID: 12381545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized glucocorticoid resistance accompanied with an adrenocortical adenoma and caused by a novel point mutation of human glucocorticoid receptor gene.
    Zhu HJ; Dai YF; Wang O; Li M; Lu L; Zhao WG; Xing XP; Pan H; Li NS; Gong FY
    Chin Med J (Engl); 2011 Feb; 124(4):551-5. PubMed ID: 21362280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes.
    Nicolaides NC; Charmandari E
    Hormones (Athens); 2017 Apr; 16(2):124-138. PubMed ID: 28742501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes.
    Charmandari E; Kino T
    Eur J Clin Invest; 2010 Oct; 40(10):932-42. PubMed ID: 20649902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid resistant syndromes--molecular basis and clinical presentations.
    Brönnegård M; Stierna P; Marcus C
    J Neuroendocrinol; 1996 Jun; 8(6):405-15. PubMed ID: 8809670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular aspects of glucocorticoid sensitivity].
    Faria CD; Longui CA
    Arq Bras Endocrinol Metabol; 2006 Dec; 50(6):983-95. PubMed ID: 17221103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid resistance.
    Orbak Z
    Biochemistry (Mosc); 2006 Oct; 71(10):1073-81. PubMed ID: 17125454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?
    Kino T; Chrousos GP
    Ann N Y Acad Sci; 2004 Jun; 1024():153-67. PubMed ID: 15265780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology.
    Kino T; Kopp JB; Chrousos GP
    J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):283-90. PubMed ID: 11282284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism.
    De Martino MU; Bhattachryya N; Alesci S; Ichijo T; Chrousos GP; Kino T
    Mol Endocrinol; 2004 Apr; 18(4):820-33. PubMed ID: 14739255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
    Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Generalized Glucocorticoid Resistance and Hypersensitivity Syndromes: A 2021 Update.
    Nicolaides NC; Charmandari E
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
    Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.